These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 13734775)

  • 21. Effect of several anti-leprosy drugs on multiplication of human leprosy bacilli in footpads of mice.
    SHEPARD CC; CHANG YT
    Proc Soc Exp Biol Med; 1962 Mar; 109():636-8. PubMed ID: 13911661
    [No Abstract]   [Full Text] [Related]  

  • 22. [Concentrations of PAS and INH in sputa of patients receiving them orally and the method for their inactivation. Report 1. Free PAS concentrations in sputum].
    HONJO S
    Kekkaku; 1960 Feb; 35():104-8. PubMed ID: 14402967
    [No Abstract]   [Full Text] [Related]  

  • 23. [The effect of para-aminosalicylic acid on the development of experimental goiter].
    FEST T; CELEMEN A; FEST G; ALMASI S
    Rev Sci Med; 1960; 5():145-8. PubMed ID: 13699222
    [No Abstract]   [Full Text] [Related]  

  • 24. Modification by para-aminosalicylic acid and sulfamethazine of the isoniazid inactivation in man.
    Tiitinen H
    Scand J Respir Dis; 1969; 50(4):281-90. PubMed ID: 5380785
    [No Abstract]   [Full Text] [Related]  

  • 25. The metabolic effect of p-aminosalicylic acid.
    CHRISTENSEN LK
    Acta Endocrinol (Copenh); 1959 Aug; 31():608-10. PubMed ID: 13810100
    [No Abstract]   [Full Text] [Related]  

  • 26. [Metabolism of isoniazid in presence of PAS; therapeutic results].
    BORSARI G; LAUENER H; FAVEZ G
    Schweiz Z Tuberc Pneumonol; 1958; 15(4):214-6. PubMed ID: 13602781
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cholesterol metabolism, acetylation processes and thiamine].
    OSTROVSKII IuM
    Biull Eksp Biol Med; 1961 Jul; 52():62-4. PubMed ID: 13731532
    [No Abstract]   [Full Text] [Related]  

  • 28. [Spontaneous development of primary tuberculosis and its changes under the influence of chemotherapy].
    MASSE NP
    Monatsschr Kinderheilkd (1902); 1961 Sep; 109():409-15. PubMed ID: 14470905
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of insulin on isoniazid and para-aminosalicylic acid metabolism in patients with pulmonary tuberculosis].
    Savula MM; Kiselova ES
    Probl Tuberk; 1974; (8):43-6. PubMed ID: 4409368
    [No Abstract]   [Full Text] [Related]  

  • 30. [Isonicotinic acid hydrazide, PAS and T-40 metabolism in the animal organism].
    JAKIMOWSKA K
    Postepy Biochem; 1958; 4(4):471-9. PubMed ID: 13623519
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of neomycin, para-aminosalicylic-acid and other antibacterial drugs on serum cholesterol level of man.
    SAMUEL P
    Proc Soc Exp Biol Med; 1959 Oct; 102():194-6. PubMed ID: 14441288
    [No Abstract]   [Full Text] [Related]  

  • 32. Toxicity to para-aminosalicylic acid and isoniazid.
    ADRIANY J
    Dis Chest; 1960 Jul; 38():107-8. PubMed ID: 13791945
    [No Abstract]   [Full Text] [Related]  

  • 33. Antagonism of the oxidative dissimilation of p-aminobenzoic acid by p-aminosalicylic acid.
    DURHAM NN; HUBBARD JS
    Nature; 1959 Oct; 184(Suppl 18)():1398. PubMed ID: 13818834
    [No Abstract]   [Full Text] [Related]  

  • 34. [Report of sixteen cases treated with isoniazid in combination with para aminosalicylic acid].
    ATAK C; OZGEN ZS
    Praxis; 1956 Oct; 45(41):946-8. PubMed ID: 13389133
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of para-aminosalicylic acid (PAS), isoniazid (INH) and 2-ethylisothionicotinamide (TH1314) on the activity of the thyroid gland of the rat.
    SIMILA S; LAHTINEN K; MAKINEN E; NAATANEN E; RIEKKINEN P
    Acta Tuberc Pneumol Scand; 1962; 42():73-8. PubMed ID: 13913017
    [No Abstract]   [Full Text] [Related]  

  • 36. [Interaction of antitubercular agents. I. Combined action of rifampicin, isonicotinic acid hydrazide, streptomycin and para-aminosalicylic acid on the growth of strains of tubercle bacilli].
    Janowiec M; Zwolska-Kwiek Z; Wiśniewska A; Wróblewska H
    Pneumonol Pol; 1977 Jun; 45(6):425-30. PubMed ID: 406600
    [No Abstract]   [Full Text] [Related]  

  • 37. The quantitative determination of isoniazid and para-aminosalicylic acid in body fluids.
    MAHER JR; WHITNEY JM; CHAMBERS JS; STANONIS DJ
    Am Rev Tuberc; 1957 Nov; 76(5):852-61. PubMed ID: 13478839
    [No Abstract]   [Full Text] [Related]  

  • 38. The influence of para-aminosalicylic acid on isonicotinic acid hydrazide blood levels after oral and intravenous administration.
    Kreukniet J; Blom van Assendelft PM; Mouton RP; Tasman A; Bangma PJ
    Scand J Respir Dis; 1966; 47(4):236-43. PubMed ID: 5182291
    [No Abstract]   [Full Text] [Related]  

  • 39. Inactivation of isoniazid (INH) in Swedish tuberculous patients before and during treatment with para-aminosalicylic acid (PAS).
    Hanngren A; Borgå O; Sjöqvist F
    Scand J Respir Dis; 1970; 51(1):61-9. PubMed ID: 5456864
    [No Abstract]   [Full Text] [Related]  

  • 40. Canadian survey to determine the rate of drug resistance to isoniazid, PAS and streptomycin in newly detected untreated tuberculosis patients and retreatment cases.
    Hershfield ES; Eidus L; Helbecque DM
    Int J Clin Pharmacol Biopharm; 1979 Sep; 17(9):387-93. PubMed ID: 115802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.